KANCHI404.95

Kanchi Karpooram Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXDAICHIELANTASGRAUWEILINDOKEMJYOTIRES
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Non-current Assets
+ Property, Plant & Equipment50.767.673.9
+ Capital Work-in-Progress19.16.80.1
+ Other Intangibles0.0
+ Long-term Loans0.50.75.7
+ Other Non-current Financial Assets20.5
+ Other Non-current Assets0.10.10.1
Current Assets
+ Inventories64.669.680.0
+ Trade Receivables12.113.819.9
+ Cash & Cash Equivalents1.71.80.9
+ Other Bank Balances47.549.711.2
+ Short-term Loans5.84.20.3
+ Other Current Financial Assets1.91.51.2
Total Assets207.0220.9227.7
Equity
+ Equity Share Capital4.34.34.3
+ Other Equity / Reserves194.6208.5213.4
Total Equity198.9212.8217.8
Liabilities
+ Deferred Tax Liabilities1.01.52.4
+ Trade Payables1.71.40.9
+ Other Current Liabilities3.10.30.8
Current Liabilities7.3
Total Equity & Liabilities207.0220.9227.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.